| ViraEpi504 | Epstein barr virus (EBV) | Wp | NA | 14077 | 14077 | Intermediate | 58.33% | Cell line | B lymphocyte culture post 14 day infection | 12 clones | NA | Bisulfite seq, Methylation Specific PCR (MSP) | 16920819 | | ViraEpi506 | Epstein barr virus (EBV) | Wp | NA | 14101 | 14101 | Intermediate | 50% | Cell line | B lymphocyte culture post 14 day infection | 12 clones | NA | Bisulfite seq, Methylation Specific PCR (MSP) | 16920819 | | ViraEpi554 | Epstein barr virus (EBV) | Wp | NA | 14288 | 14288 | intermediate | 61.50% | Cell line | EBH41.2 LCL cell line | 13 clones | NA | Bisulfite seq, Methylation Specific PCR (MSP) | 16920819 | | ViraEpi666 | Epstein barr virus (EBV) | Wp | NA | 14101 | 14101 | Intermediate | 60% | Cell line | 11W LCL 2 cell line | 10 clones | NA | Bisulfite seq, Methylation Specific PCR (MSP) | 16920819 | | ViraEpi722 | Epstein barr virus (EBV) | Wp | NA | 13976 | 13976 | Intermediate | 50% | Wp-restricted cell line | Ava-BL c.1 cell line | 12 clones | NA | Bisulfite seq, Methylation Specific PCR (MSP) | 16920819 | | ViraEpi741 | Epstein barr virus (EBV) | Wp | NA | 13956 | 13956 | Intermediate | 57.14% | Wp-restricted cell line | Oku-BL c.1 cell line | 14 clones | NA | Bisulfite seq, Methylation Specific PCR (MSP) | 16920819 | | ViraEpi750 | Epstein barr virus (EBV) | Wp | NA | 14143 | 14143 | Intermediate | 50% | Wp-restricted cell line | Oku-BL c.1 cell line | 14 clones | NA | Bisulfite seq, Methylation Specific PCR (MSP) | 16920819 | | ViraEpi812 | Epstein barr virus (EBV) | Wp | NA | 14259 | 14259 | Intermediate | 50% | Wp-restricted cell line | Awia-BL c.3 cell line | 10 clones | NA | Bisulfite seq, Methylation Specific PCR (MSP) | 16920819 | | ViraEpi813 | Epstein barr virus (EBV) | Wp | NA | 14261 | 14261 | Intermediate | 50% | Wp-restricted cell line | Awia-BL c.3 cell line | 10 clones | NA | Bisulfite seq, Methylation Specific PCR (MSP) | 16920819 | | ViraEpi834 | Epstein barr virus (EBV) | Wp | NA | 14288 | 14288 | Intermediate | 50% | Wp-restricted cell line | Awia-BL c.4 cell line | 12 clones | NA | Bisulfite seq, Methylation Specific PCR (MSP) | 16920819 | | ViraEpi835 | Epstein barr virus (EBV) | Wp | NA | 14290 | 14290 | Intermediate | 58.33% | Wp-restricted cell line | Awia-BL c.4 cell line | 12 clones | NA | Bisulfite seq, Methylation Specific PCR (MSP) | 16920819 | | ViraEpi840 | Epstein barr virus (EBV) | Wp | NA | 14462 | 14462 | Intermediate | 50% | Wp-restricted cell line | Awia-BL c.4 cell line | 12 clones | NA | Bisulfite seq, Methylation Specific PCR (MSP) | 16920819 | | ViraEpi880 | Epstein barr virus (EBV) | Wp | NA | 14462 | 14462 | Intermediate | 60% | EBNA2+/LMP1- | Awia-BL c.2 cell line | 10 clones | NA | Bisulfite seq, Methylation Specific PCR (MSP) | 16920819 | | ViraEpi898 | Epstein barr virus (EBV) | Wp | NA | 14391 | 14391 | Intermediate | 66.66% | Spleen | Frozen spleen samples from patients | 6 samples from patient 1 | EBV-associated hemophagocytic syndrome (EBV-AHS) | Bisulphite PCR | 12767005 | | ViraEpi918 | Epstein barr virus (EBV) | Wp | NA | 14391 | 14391 | Intermediate | 66.66% | Spleen | Frozen spleen samples from patients | 6 samples from patient 2 | EBV-associated hemophagocytic syndrome (EBV-AHS) | Bisulphite PCR | 12767005 |